Thrivent Financial For Lutherans Has $4.93 Million Position in HCP, Inc. (NYSE:HCP)

Thrivent Financial For Lutherans increased its stake in shares of HCP, Inc. (NYSE:HCP) by 3.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 189,176 shares of the real estate investment trust’s stock after buying an additional 6,324 shares during the quarter. Thrivent Financial For Lutherans’ holdings in HCP were worth $4,933,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Sawyer & Company Inc bought a new position in shares of HCP during the 4th quarter worth approximately $725,000. Beacon Investment Advisory Services Inc. lifted its position in shares of HCP by 109.3% during the 3rd quarter. Beacon Investment Advisory Services Inc. now owns 18,570 shares of the real estate investment trust’s stock worth $517,000 after buying an additional 9,698 shares during the period. California Public Employees Retirement System lifted its position in shares of HCP by 3.9% during the 3rd quarter. California Public Employees Retirement System now owns 1,164,448 shares of the real estate investment trust’s stock worth $32,407,000 after buying an additional 43,888 shares during the period. Arbor Wealth Management LLC lifted its position in shares of HCP by 10.2% during the 3rd quarter. Arbor Wealth Management LLC now owns 146,389 shares of the real estate investment trust’s stock worth $3,955,000 after buying an additional 13,512 shares during the period. Finally, New York State Common Retirement Fund lifted its position in shares of HCP by 0.7% during the 3rd quarter. New York State Common Retirement Fund now owns 1,053,000 shares of the real estate investment trust’s stock worth $29,305,000 after buying an additional 7,800 shares during the period. Institutional investors and hedge funds own 88.49% of the company’s stock.

How to Become a New Pot Stock Millionaire

Several research firms recently commented on HCP. Zacks Investment Research upgraded HCP from a “sell” rating to a “hold” rating in a research report on Monday, March 26th. Wells Fargo cut their target price on HCP from $31.00 to $27.00 and set a “market perform” rating for the company in a research report on Tuesday, March 20th. Bank of America upgraded HCP from a “neutral” rating to a “buy” rating and raised their target price for the stock from $22.63 to $25.00 in a research report on Thursday, March 8th. Royal Bank of Canada restated a “hold” rating and set a $27.00 target price on shares of HCP in a research report on Friday, February 23rd. Finally, UBS reaffirmed a “sell” rating and set a $21.00 price target (down from $25.00) on shares of HCP in a report on Wednesday, February 21st. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have assigned a buy rating to the company’s stock. HCP has a consensus rating of “Hold” and a consensus price target of $27.50.

In other news, insider Kendall K. Young bought 14,000 shares of the stock in a transaction dated Wednesday, February 14th. The stock was bought at an average cost of $21.91 per share, with a total value of $306,740.00. Following the purchase, the insider now owns 48,544 shares of the company’s stock, valued at $1,063,599.04. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. 0.14% of the stock is currently owned by company insiders.

HCP stock traded up $0.04 during midday trading on Friday, reaching $23.20. 3,723,382 shares of the company’s stock traded hands, compared to its average volume of 4,226,402. The stock has a market capitalization of $10,891.08, a price-to-earnings ratio of 11.90, a P/E/G ratio of 4.27 and a beta of 0.26. HCP, Inc. has a 1-year low of $21.48 and a 1-year high of $33.67. The company has a debt-to-equity ratio of 1.23, a current ratio of 0.31 and a quick ratio of 0.31.

HCP (NYSE:HCP) last released its earnings results on Tuesday, February 13th. The real estate investment trust reported $0.48 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.47 by $0.01. The company had revenue of $443.30 million during the quarter, compared to analysts’ expectations of $448.54 million. HCP had a return on equity of 6.99% and a net margin of 22.37%. The business’s revenue for the quarter was down 17.9% on a year-over-year basis. During the same period last year, the firm earned $0.59 EPS. equities analysts expect that HCP, Inc. will post 1.81 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Thrivent Financial For Lutherans Has $4.93 Million Position in HCP, Inc. (NYSE:HCP)” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/04/08/thrivent-financial-for-lutherans-buys-6324-shares-of-hcp-inc-hcp.html.

HCP Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply